Literature DB >> 19554473

Efficient amplification of light and heavy chain variable regions and construction of a non-immune phage scFv library.

Maneerat Koohapitagtam1, Suang Rungpragayphan, Ratchanee Hongprayoon, Wichai Kositratana, Theerapol Sirinarumitr.   

Abstract

Non-immune phage scFv library is one of the most attractive resources for therapeutics, diagnostics and basic research. As a matter of fact, quality of the library is limited by inefficient PCR cloning of antibody genes using degenerated primers. PCR using this type of primers is difficult to optimize conditions for efficient amplification, and therefore causes loss of antibody diversities. To overcome this problem, we described a novel two-step amplification of V(kappa) and V(H) genes with newly designed primer sets. Initially, we amplified V(kappa) and V(H) genes from their signal sequences to the joining region to keep antibody diversity as large as possible. Thereafter, highly degenerated primers were used to amplify the V(kappa) and V(H) genes from the framework region 1 to the joining region. The V(kappa) and V(H) genes from the second PCR then were linked by PCR overlapping extension to generate the scFv library. Fifteen clones from the library were randomly picked and sequenced, and the diversity of full-length scFvs was confirmed. Expression capability of clones in the library was 80% after confirmation using colony hybridization. The results demonstrated the efficiency of this strategy and the primer sets for construction of the scFv library.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554473     DOI: 10.1007/s11033-009-9583-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

Review 1.  Phage display of antibody fragments.

Authors:  A Pini; L Bracci
Journal:  Curr Protein Pept Sci       Date:  2000-09       Impact factor: 3.272

Review 2.  Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses.

Authors:  R Kofler; S Geley; H Kofler; A Helmberg
Journal:  Immunol Rev       Date:  1992-08       Impact factor: 12.988

3.  Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.

Authors:  Takayuki Okamoto; Yohei Mukai; Yasuo Yoshioka; Hiroko Shibata; Maki Kawamura; Yoko Yamamoto; Shinsaku Nakagawa; Haruhiko Kamada; Takao Hayakawa; Tadanori Mayumi; Yasuo Tsutsumi
Journal:  Biochem Biophys Res Commun       Date:  2004-10-15       Impact factor: 3.575

4.  A simple hybridoma screening method for high-affinity monoclonal antibodies using the signal ratio obtained from time-resolved fluorescence assay.

Authors:  Kenji Daigo; Sui Sugita; Yasuhiro Mochizuki; Hiroko Iwanari; Kanae Hiraishi; Kenjiro Miyano; Tatsuhiko Kodama; Takao Hamakubo
Journal:  Anal Biochem       Date:  2006-01-17       Impact factor: 3.365

5.  Immunoglobulin production by lymphocyte hybridomas.

Authors:  G Köhler; H Hengartner; M J Shulman
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

6.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family.

Authors:  T Chardès; S Villard; G Ferrières; M Piechaczyk; M Cerutti; G Devauchelle; B Pau
Journal:  FEBS Lett       Date:  1999-06-11       Impact factor: 4.124

9.  Making antibody fragments using phage display libraries.

Authors:  T Clackson; H R Hoogenboom; A D Griffiths; G Winter
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

Review 10.  Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Authors:  Greg L Plosker; David P Figgitt
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more
  1 in total

1.  Assessment of antibody library diversity through next generation sequencing and technical error compensation.

Authors:  Marco Fantini; Luca Pandolfini; Simonetta Lisi; Michele Chirichella; Ivan Arisi; Marco Terrigno; Martina Goracci; Federico Cremisi; Antonino Cattaneo
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.